- Published at
- by manilatimes.net
mixed
mixed
News for Neos Therapeutics, Inc. (NEOS)
- Published at
- by globenewswire.com
mixedmixedAdverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program
REDWOOD CITY, Calif., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a company pioneering the use of gene therapy as a...- Published at
- by globenewswire.com
mixedmixedADHD Therapeutics Market Size Worth USD 19740 Million by 2030 at 7.80% CAGR – Report by Market Research Future (MRFR)
ADHD Therapeutics Market Trends and Insights by Drug Type (Stimulants and Non-Stimulants), Age Group (Pediatric & Adolescent and Adults), End-User...- Published at
- by prnewswire.com
mixedmixedGlobal Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
/PRNewswire/ -- The "Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report and Forecast 2023-2031" report has been added to...- Published at
- by globenewswire.com
mixedmixedAttention Deficit Hyperactivity Disorder Market to Register a Steady CAGR of 4.40% Between 2023 – 2031 | Growth Plus Reports
Newark, New Castle, USA, April 03, 2023 (GLOBE NEWSWIRE) -- The global attention deficit hyperactivity disorder market, estimated at US$ 13.60 billion in...- Published at
- by seekingalpha.com
mixedmixedAytu BioPharma, Inc. (AYTU) CEO Josh Disbrow on Q4 2022 Results - Earnings Call Transcript
Start Time: 16:30 End Time: 17:12 Aytu BioPharma, Inc.- Published at
- by marketscreener.com
mixedmixedAllarity Therapeutics Appoints Seasoned Biotechnology Executive Jerry McLaughlin to Board of Directors
Press release Cambridge, MA U.S.A. — Allarity Therapeutics, Inc. , a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP®... | September 26, 2022- Published at
- by marketscreener.com
mixedmixedAltimmune : Appoints Richard Eisenstadt as Chief Financial Officer - Form 8-K
Altimmune Appoints Richard Eisenstadt as Chief Financial Officer GAITHERSBURG, MD, -- December 13, 2021 -- Altimmune, Inc. , a clinical-stage biopharmaceutical company focused... | December 13, 2021- Published at
- by markets.businessinsider.com
mixedmixedAltimmune Appoints Richard Eisenstadt As Chief Financial Officer - Quick Facts
(RTTNews) - Biopharmaceutical company Altimmune, Inc. (ALT) announced Monday the appointment of Richard Eisenstadt as Chief Financial Officer, eff...- Published at
- by thestreet.com
neutralneutralLife Biosciences Appoints Seasoned Biopharma Executive Jerry McLaughlin As CEO
BOSTON, July 1, 2021 /PRNewswire/ -- Life Biosciences, a pioneering life sciences company targeting the biology of aging, today announced that the Company's- Published at
- by cnafinance.com
positivepositiveNEOS Stock: Neos Therapeutics Climbs on Merger Hopes
NEOS stock is screaming for the top as investors await the results of a special meeting surrounding a potential merger with AYTU.- Published at
- by marketscreener.com
mixedmixedHalper Sadeh LLP : Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS
NEW YORK, Jan. 30, 2021 /PRNewswire/ --?Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: ... | January 31, 2021- Published at
- by prnewswire.com
mixedmixedHalper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: CounterPath Corporation (NASDAQ: CPAH)...- Published at
- by thestreet.com
mixedmixedHalper Sadeh LLP Continues To Investigate The Following Mergers; Shareholders Are Encouraged To Contact The Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS
NEW YORK, Jan. 30, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:- Published at
- by pennystocks.com
positivepositive4 Penny Stocks Nearing 2021 Highs But Are They A Buy Right Now?
Are These On Your List Of Penny Stocks To Buy Or Avoid? This year is off to a roaring start, and penny stocks are partly to blame. It’s the end of January, a...- Published at
- by pennystocks.com
mixedmixedMaking A List Of Penny Stocks Today? 5 Biotech Stocks To Watch
Are These 5 Cheap Biotech Penny Stocks Worth It? With only a week or so left in January, penny stocks remain a hot item in the market. As an investor, it’s i...- Published at
- by benzinga.com
mixedmixedA Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents ...